000 01457 a2200397 4500
005 20250517221454.0
264 0 _c20190103
008 201901s 0 0 eng d
022 _a1744-8336
024 7 _a10.1080/14787210.2018.1483721
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDard, Céline
245 0 0 _aManagement of toxoplasmosis in transplant recipients: an update.
_h[electronic resource]
260 _bExpert review of anti-infective therapy
_c06 2018
300 _a447-460 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntiprotozoal Agents
_xadministration & dosage
650 0 4 _aHematopoietic Stem Cell Transplantation
_xmethods
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aOrgan Transplantation
_xmethods
650 0 4 _aRisk Factors
650 0 4 _aToxoplasma
_xisolation & purification
650 0 4 _aToxoplasmosis
_xdiagnosis
650 0 4 _aTransplant Recipients
700 1 _aMarty, Pierre
700 1 _aBrenier-Pinchart, Marie-Pierre
700 1 _aGarnaud, Cécile
700 1 _aFricker-Hidalgo, Hélène
700 1 _aPelloux, Hervé
700 1 _aPomares, Christelle
773 0 _tExpert review of anti-infective therapy
_gvol. 16
_gno. 6
_gp. 447-460
856 4 0 _uhttps://doi.org/10.1080/14787210.2018.1483721
_zAvailable from publisher's website
999 _c28483891
_d28483891